Shenzhen Hepalink Pharmaceutical Group Co Ltd 2021 Sustainability Report
Company: Shenzhen Hepalink Pharmaceutical Group Co Ltd
Sector: Manufacturing
Country: China
Year: 2021
Type: Sustainability Report
Pages: 37
The report presents the Group's 2021 ESG policies and performance for operations in Shenzhen and the United States. It reports 65,879.6 tonnes of total GHG emissions, including Scope 1 and Scope 2 figures, and total energy consumption of 158,729.4 kWh in '000s. Community highlights include establishing a Biopharm Research Institute and donating approximately RMB2.7 million in total.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.